Theravance Biopharma, Inc. (TBPH) Stock Price History
Historical prices from 2014 to 2026
Loading 10-year price history...
TBPH Historical Performance
Short-Term Returns
TBPH Stock Price Trajectory (2014–2026)
As of May 7, 2026, Theravance Biopharma, Inc. (TBPH) trades at $16.94, representing a +67.9% return over the past year. The stock has delivered a -12.6% total return over five years (-2.7% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $43.44 on June 26, 2017. From this peak, TBPH has corrected -61.0%, currently trading 6% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers INVA (+20.4% 1Y), PRGO (-50.3% 1Y), and SUPN (+58.6% 1Y), TBPH has underperformed the peer group average. Compare TBPH vs INVA →
TBPH Historical Price Data (2014–2026)
Showing 30 of 3,012 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-06 | 16.71 | 17.05 | 16.68 | 16.94 | 313K | +1.26% |
| 2026-05-05 | 16.98 | 17.17 | 16.65 | 16.73 | 122K | -1.06% |
| 2026-05-04 | 16.68 | 16.93 | 16.60 | 16.91 | 191K | +0.71% |
| 2026-05-01 | 16.81 | 16.84 | 16.57 | 16.79 | 288K | +0.30% |
| 2026-04-30 | 16.77 | 16.82 | 16.53 | 16.74 | 191K | +0.42% |
| 2026-04-29 | 16.58 | 16.75 | 16.45 | 16.67 | 292K | -0.54% |
| 2026-04-28 | 16.86 | 16.99 | 16.54 | 16.76 | 309K | -0.30% |
| 2026-04-27 | 16.64 | 16.95 | 16.38 | 16.81 | 250K | +2.13% |
| 2026-04-24 | 16.26 | 16.50 | 16.14 | 16.46 | 269K | +0.92% |
| 2026-04-23 | 16.54 | 16.54 | 16.30 | 16.31 | 293K | -1.57% |
| 2026-04-22 | 16.72 | 16.74 | 16.32 | 16.57 | 432K | -0.30% |
| 2026-04-21 | 16.67 | 16.94 | 16.46 | 16.62 | 479K | -0.60% |
| 2026-04-20 | 16.79 | 17.14 | 16.60 | 16.72 | 462K | -2.96% |
| 2026-04-17 | 16.97 | 17.24 | 16.74 | 17.23 | 407K | +2.68% |
| 2026-04-16 | 16.58 | 16.80 | 16.36 | 16.78 | 499K | +0.84% |
| 2026-04-15 | 16.66 | 16.80 | 16.40 | 16.64 | 342K | +0.24% |
| 2026-04-14 | 16.66 | 16.98 | 16.46 | 16.60 | 473K | +0.61% |
| 2026-04-13 | 16.43 | 16.57 | 16.21 | 16.50 | 272K | +0.92% |
| 2026-04-10 | 16.60 | 16.60 | 16.21 | 16.35 | 357K | -1.21% |
| 2026-04-09 | 16.45 | 16.58 | 16.38 | 16.55 | 233K | -0.30% |
| 2026-04-08 | 16.78 | 16.82 | 16.52 | 16.60 | 281K | +0.24% |
| 2026-04-07 | 16.22 | 16.58 | 16.03 | 16.56 | 416K | +2.86% |
| 2026-04-06 | 16.17 | 16.45 | 16.02 | 16.10 | 513K | +0.50% |
| 2026-04-02 | 15.81 | 16.13 | 15.73 | 16.02 | 346K | +1.14% |
| 2026-04-01 | 16.40 | 16.48 | 15.75 | 15.84 | 677K | -2.40% |
| 2026-03-31 | 15.40 | 16.28 | 15.40 | 16.23 | 808K | +6.36% |
| 2026-03-30 | 14.79 | 15.41 | 14.71 | 15.26 | 559K | +1.19% |
| 2026-03-27 | 15.09 | 15.25 | 14.86 | 15.08 | 560K | -0.72% |
| 2026-03-26 | 15.32 | 15.75 | 15.16 | 15.19 | 383K | -0.65% |
| 2026-03-25 | 15.04 | 15.36 | 14.95 | 15.29 | 516K | +2.62% |
See TBPH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TBPH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TBPH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTBPH — Frequently Asked Questions
Quick answers to the most common questions about buying TBPH stock.
How has TBPH stock performed recently?
TBPH returned +67.9% over the past year, beating its 5-year annualized CAGR of -2.7%. The stock trades above its 200-day moving average, confirming the uptrend.
What is TBPH's all-time high price?
Theravance Biopharma, Inc. reached $43.44 on 2017-06-26. The 52-week high is $21.03. Current 1-year return of +67.9% places the stock closer to historical peaks.
Where can I download TBPH historical price data?
This page provides TBPH daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.